CURRICULUM VITAE 2012, March

Size: px
Start display at page:

Download "CURRICULUM VITAE 2012, March"

Transcription

1 CURRICULUM VITAE 2012, March OVERVIEW INFORMATION Name: MARHOUM EL FILALI Kamal Date and birthplace: July 16, 1958 in Casablanca, Sex: Male Nationality: Moroccan Contact Information: Business contact Personal details Address: Faculté de Médecine Address: Résidence Mawlid 3, Appt C54 19, Rue Tarik Bnou Ziad Rue Abou Taour Casablanca, Casablanca, Tel: Tel: Fax: Areas of expertise: - Clinical experience in infectious diseases, particularly in care of HIV infected patients - Quantification of antiretroviral drugs needs for HIV infected patients in - HIV/AIDS prevention campaigns - Evaluation of projects related to HIV/AIDS - Education and training in the field of infectious diseases and HIV infection Expertise related to HIV/AIDS - In : Collaboration with the National AIDS Program Commitment in the Moroccan experience of access to care and to antiretroviral therapy Involvement in many national campaigns of prevention In charge of HIV infection course in the Faculty of Medicine and Pharmacy of Casablanca - At the international level : Collaboration as consultant with UNAIDS (Republic of Congo in 2001) Contribution to the development of an african consensus on antiretroviral therapy ( Dakar, October 2000 ) Collaboration as consultant with WHO-EMRO (Republic of Yemen in 2007) Collaboration as consultant with WHO-EMRO (Republic of Syria in 2009) Currently preparing a basic training on HIV infection in collaboration with WHO-EMRO

2 EDUCATION 1993 Certificate in Infected Patient Resuscitation Xavier Bichat University Paris, France 1993 Certificate in AIDS and retroviral diseases Xavier Bichat University, Paris, France 1993 Certificate Résident Etranger du Collège de Médecine des Hôpitaux de Paris 1989 Maghreban Certificate in Health Sciences Pedagogy Collège de Médecine des Hôpitaux de Paris, France Medical School, Casablanca, 1985 MD Medical School, Casablanca, Medical School, Casablanca, 1976 Baccalaureate University of Bordeaux, France Lycée Lyautey, Casablanca, TRAINING 2010, October Antifungal preceptorship meeting. University of South Manchester, UK 2008, February Human Participants Protection Education for Research Teams NIH, online course 2007, June Advanced Course on Security WHO, online course 2006, October GCP Training for investigators Roche, Casablanca, 2006, April Course on applied regression modelling University of Bristol and University of Bern, Cape Town, South Africa 2005, July Course : Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies World Bank Institute, Beirut, Lebanon 2002, July Training : Clinical studies monitoring Georges Pompidou European Hospital, Paris, France 2001, March Atelier de mise à niveau des consultants francophones UNAIDS / WHO, Rabat, 2000, June The 2 nd african workshop on antiretrovirals Dakar, Senegal 1999, July The first African Workshop on Antiretrovirals Dakar, Senegal

3 1997, May Symposium on HIV infection Mediterranean Society of Infectious and Parasitic Diseases, Cairo, Egypt 1996, March Course on Research Methodology Medical School, Casablanca, 1995, April Course on biostatistics Medical School, Casablanca, Training : Intensive care Bichat-Claude Bernard Hospital, Paris, France 1992, June Training : Digestive endoscopia Beaujon Hospital, Paris, France 1990, January Training : HIV infection care practice Bichat-Claude Bernard Hospital Paris, France WORKING EXPERIENCES Permanent positions Since 2011 Since 2003 Since 1997 Since 1997 Since 1988 Since 1987 Head of the Infectious Diseases Unit of Ibn Rochd University Hospital. Member of the National Committee of Management of HIV infection () Responsibility of ARVs quantification for the treatment of HIV infected patients in In charge of HIV infection course in the Medical School of Casablanca National Board member of Association de Lutte Contre le Sida Physician in charge of management of HIV infection in the Infectious Diseases Unit of Ibn Rochd University Hospital Academic positions (Medical School of Casablanca) 1993 Professor of Infectious Diseases Associate Professor Assistant Resident Medical student training

4 INVOLVEMENT IN RESEARCH GRANTS : Evaluation of Subcutaneous Proleukin in a Randomized International Trial (ESPRIT001), a randomized, open label, phase III, international study of subcutaneous recombinant interleukin-2 (Proleukin ) in patients with HIV-1 infection and CD4 + Cell Counts 300/mm 3. Site principal investigator: Hakima Himmich The site of the Infectious Diseases Unit of Ibn Rochd University Hospital has enrolled 26 participants. Role in this research: Site co- investigator. Amount of money in the research grant: GBP : Study of Aldesleukin with and without Antiretroviral Therapy (STALWART : ESPRIT002), a randomized, open-label, international study of subcutaneous recombinant interleukin-2 (Aldesleukin ) with and without concomitant antiretroviral therapy in patients with HIV-1 infection and CD4 + Cell Counts 300/mm 3. Site principal investigator: Hakima Himmich The site of the Infectious Diseases Unit of Ibn Rochd University Hospital has enrolled 1 patient. Role in this research: Site co- investigator. Amount of money in the research grant: GBP : The SMART Study, a large, simple trial comparing the long-term clinical consequences of two Strategies for Management of Anti-Retroviral Therapy (Protocol CPCRA 065), the drug conservation strategy, a strategy aimed at conserving drugs through episodic use of antiretroviral treatment for the minimum time to maintain CD4+ cell count > 250 cells/mm3 versus the viral suppression strategy, a strategy aimed at suppressing viral load as much as possible, immediately following randomization and throughout follow up, irrespective of CD4+ cell count. Site principal investigator: Hakima Himmich The site of the Infectious Diseases Unit of Ibn Rochd University Hospital has enrolled 42 patients. Role in this research: Site investigator. Amount of money in the research grant: USD ongoing : Strategic Timing of AntiRetroviral Treatment (START), a randomized study to determine whether immediate initiation of antiretroviral treatment (ART) is superior to deferral of ART until the CD4+ declines below 350 cells/mm 3 in terms of morbidity and mortality in HIV-1 infected persons who are antiretroviral naïve with a CD4+ count above 500 cells/mm 3. The site of the Infectious Diseases Unit of Ibn Rochd University Hospital has included 21 patients and the enrolment is ongoing. Role in this research: site principal investigator. Amount of money in the research grant: USD (if the goal of 50 patients is reached) : The Antiretroviral Treatment in Lower Income Countries (ART-LINC) Collaboration to define prognosis of HIV-infected patients treated with HAART in resourcepoor settings, to compare experiences between different settings, delivery modes, and types of monitoring and to compare prognosis in resource-limited settings with that observed in industrialized nations. Principal investigators: François Dabis, Mathias Egger, Mauro Schechter The site of the Infectious Diseases Unit of Ibn Rochd University Hospital has participated with its cohort data. Role in this research: clinic representative. Research conducted by the University of Bern and the University of Bordeaux. Financial support of ANRS (France), CIHR (Canada) and NIH. Amount of money in the research grant: USD

5 CONSULTATIONS AND PROGRAMMATIC EXPERIENCE 2011 Consultation on provider initiated HIV testing in health care settings 2010 Consultation on HIV prophylaxis in case of sexual violence 2006 Consultation on sharp waste management in hospital (2 nd phase) 2004 Consultation on sharp waste management in hospital 2003 Assessment and strengthening of referral centers for HIV infection management 2001 Consultation on implementation of Access Initiative Republic of Congo UNAIDS Since 2000 Coordinator of the education program for patients under ART 2000 Contribution to the development of an African consensus on ART Casablanca Dakar, Senegal Infectious diseases unit/gsk foundation Since 1997 Consultation on ARVs procurement and supplying Since 1993 Collaboration with the National AIDS Program REGIONAL EXPERIENCE March 2009 July 2007 Syria : Consultation for the development of the GFATM proposal (WHO). Yemen : Consultation on ART for the NAP at ART sites of Sanaa and Aden (WHO) Member of the steering group of Antiretroviral Therapy in Low Income Countries (ART- LINC) collaboration Since 1994 July 2001 (Casablanca) : HIV Infection management Republic of Congo : Program Access of UNAIDS France (Paris) : HIV infection management (Casablanca) : Infectious diseases management (Casablanca) : Internal medicine diseases management.

6 PUBLICATIONS 1. Sodqi M, Marih L, Oulad Lahsen A, Bensghir R, Chakib A, Himmich H, Marhoum El Filali K. Causes de décès de 91 patients ayant une infection à VIH traités par des antirétroviraux. La Presse Médicale 2012, in press 2. Fane M, Oulad Lahsen A, Bakhatar A, Sodqi M, Marhoum El Filali K, Bahlaoui A, Chakib A. Aspergilose pulmonaire et infection à VIH (à propos de deux cas). Rev Pneumol Clin 2012, 68, 1 : Oulad Lahsen A, Rachidi T, Sodqi M, Abada R, Marhoum El Filali K. Paralysie faciale associée à la leptospirose. Médecine et Maladies Infectieuses 2010; 40, 12 : Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Marhoum El Filali K, Ezzikouri S, Abidi O, Hassar M, Wakrim L. The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve HIV1-infected individuals in Casablanca,. J Infect Dev Ctries 2009; 3(5): Kamal Marhoum El Filali, Hakima Himmich, Bloodstream infections. In : a guide to infection control in hospital (fourth edition), R. Wenzel, G. Bearman, T. Brewer, J.P. Butzler (Eds). Brookline, 2008 ; Sandrine Loubière, Kamal Marhoum El Filali, Mustapha Sodqi, Anderson Loundou, Stéphane Luchini, Susan Cleary, Jean-Paul Moatti, Hakima Himmich. When to initiate highly active antiretroviral therapy in low resource settings : the Moroccan experience. Antiviral Therapy 2008 ; 13 : Gaëlle Krikorian, Kamal Marhoum El Filali, Hakima Himmich. L accès aux médicaments sous le nouveau régime de protection des brevets : cas du sida au Maroc. Knowledge Ecology Studies 2008 ; Vol.2 (Journal on-line : 8. ART-LINC Collaboration. Antiretroviral Therapy in Lower Income Countries (ART-LINC): International collaboration of treatment cohorts. Int J Epidemiol Oct;34(5): Marih L, Sodqi M, Chakib A, Malmoussi M, Ouagari Z, Marhoum El Filali K, Himmich H. Kaposi cutané de forme tumorale: difficultés diagnostiques à propos d un cas. Rev Maroc Med Santé 2005, 22, 1 : Guide de la prise en charge de l infection à VIH. Edité par le Ministère de la Santé, avec le soutien de l OMS, sous la coordination du Pr Hakima Himmich, Rabat, Malmoussi M, Zerouali K, Aajly L, Marhoum El Filali K, El Mdaghri N, Benbachir M, Himmich H. Méningite à méningocoque de l adulte à propos de 117 cas. J Magh A Réa 2003, 43 : Marih l, Sodqi M, Bensghir R, Marhoum El Filali K, Himmich H. Monitoring for efficacy of HAART in limited resource countries. Proceeding of International AIDS Conference, July Sodqi M, Marih L, Marhoum El Filali K, Himmich H. Infection with Mycobacterium tuberculosis among HIV infected patients in. Proceedings of the XIV International AIDS Conference. July Barcelone. 14. Soussi-Abdallaoui M, El Kadioui-El Idrissi F, Chakib A, Marhoum El Filali K, Himmich H, Guessous-Idrissi N. Isospora belli au Maroc à propos de 4 nouveaux cas. Les Cahiers du Medecin 2002, 48 : Marhoum El Filali K, A Chakib, Himmich H. Accès aux antirétroviraux au Maroc. Bulletin S.M.S.M 1999, 1 : Marhoum El Filali K. Prise en charge d un malade infecté par le VIH. Les cahiers du Médecin 1998 ; 11 : Marhoum El Filali K. Prophylaxie de l infection à VIH après une exposition accidentelle au sang. Les cahiers du Médecin 1998 ; 11 : Zahraoui M, Arssi M, Marhoum El Filali K, Chakib A, Himmich H. Tuberculose et infection par le VIH. Rev Maroc Med Santé 1992, 14,1 : 7-12

in HIV/HCV-Coinfected Patients: role of the HCV sustained viral suppression

in HIV/HCV-Coinfected Patients: role of the HCV sustained viral suppression M42-Determinants M19 of HIV Sustained Viral Suppression in HIV/HCV-Coinfected Patients: role of the HCV sustained viral suppression F. Bani-Sadr 1-2, M-A Loko 2, E. Pambrun 2, M. Winnock 2, P. Carrieri

More information

Virologic suppression outcomes of second-line antiretroviral therapy in a Nigerian cohort.

Virologic suppression outcomes of second-line antiretroviral therapy in a Nigerian cohort. TUPE089 Virologic suppression outcomes of second-line antiretroviral therapy in a Nigerian cohort. Authors: Adedotun A. Adetunji 1, MBChB, MSc; Chad Achenbach 2, MD, MPH; Joseph Feinglass 3, PhD; Kristin

More information

Noam Danenberg CEO N. Danenberg Holding Ltd noam@danenberg.co.il

Noam Danenberg CEO N. Danenberg Holding Ltd noam@danenberg.co.il Noam Danenberg CEO N. Danenberg Holding Ltd noam@danenberg.co.il Experience CEO at N. Danenberg Holding (2000) Ltd) 2000 - Present (13 years) Investment Consulting Firm Consultant at Bonzai Holding Ltd.

More information

CURRICULUM VITAE PERSONAL INFORMATION. Lindell A. Busciglio, M.D. 4729 North Habana Avenue Tampa, Florida 33614 (813) 251-8444

CURRICULUM VITAE PERSONAL INFORMATION. Lindell A. Busciglio, M.D. 4729 North Habana Avenue Tampa, Florida 33614 (813) 251-8444 CURRICULUM VITAE PERSONAL INFORMATION Name: Address: Lindell A. Busciglio, M.D. 4729 North Habana Avenue 33614 (813) 251-8444 4 Columbia Drive, Suite 820 33606 Research Address: 4200 North Armenia Avenue

More information

National Institute of Health Administration of Morocco

National Institute of Health Administration of Morocco National Institute of Health Administration of Morocco Mission Initial training in Public Health and Health administration (Master degree) Continuous training in Public Health and Health administration

More information

Rapid Assessment of Sexual and Reproductive Health

Rapid Assessment of Sexual and Reproductive Health MOROCCO Rapid Assessment of Sexual and Reproductive Health and HIV Linkages This summary highlights the experiences, results and actions from the implementation of the Rapid Assessment Tool for Sexual

More information

Governing Health Systems in Africa

Governing Health Systems in Africa Governing Health Systems in Africa Contents.PMD 1 Contents.PMD 2 Governing Health Systems in Africa Edited by Martyn Sama and Vinh-Kim Nguyen Council for the Development of Social Science Research in Africa

More information

MM Thorell PhD University of the Sciences in Philadelphia, 600 South 43rd Street, Philadelphia, Pennsylvania, , USA.

MM Thorell PhD University of the Sciences in Philadelphia, 600 South 43rd Street, Philadelphia, Pennsylvania, , USA. Medical Journal of Therapeutics Africa 2007 Vol 1, No 2 Page 148 SUMMARY OF GUIDELINES FOR THE USE OF ANTIRETROVIRAL AGENTS IN HIV-INFECTED ADULTS AND ADOLESCENTS. MM Thorell PhD University of the Sciences

More information

Up to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data).

Up to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data). HIV Background, new developments, key strategies Drug Class Insight INTRODUCTION Human Immunodeficiency Virus (HIV) is the virus that can lead to Acquired Immunodeficiency Syndrome, or AIDS. No safe and

More information

The Basics of Drug Resistance:

The Basics of Drug Resistance: CONTACT: Lisa Rossi +1-412-641-8940 +1-412- 916-3315 (mobile) rossil@upmc.edu The Basics of Drug Resistance: QUESTIONS AND ANSWERS HIV Drug Resistance and ARV-Based Prevention 1. What is drug resistance?

More information

Professor Matthew Weait Birkbeck, University of London

Professor Matthew Weait Birkbeck, University of London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Professor Matthew Weait Birkbeck, University of London 1-4 April 2014, Arena and Convention Centre Liverpool THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014

More information

Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH

Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH TREATMENT FAILURE AND PATTERNS OF GENOTYPIC DRUG RESISTANCE MUTATIONS AMONG HAART EXPERIENCED HIV-1 PATIENTS AT KCMC Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH

More information

Clinical response to Highly Active Antiretroviral Treatment (HAART) in a patient with Kaposi's sarcoma: A case presentation

Clinical response to Highly Active Antiretroviral Treatment (HAART) in a patient with Kaposi's sarcoma: A case presentation ISPUB.COM The Internet Journal of Infectious Diseases Volume 6 Number 2 Clinical response to Highly Active Antiretroviral Treatment (HAART) in a patient with Kaposi's sarcoma: A case presentation Y Graza,

More information

HIV surveillance in Northern Ireland 2014

HIV surveillance in Northern Ireland 2014 HIV surveillance in Northern Ireland 2014 Contents Page 1 Surveillance arrangements 3 2 Introduction and key points 4 3 Trend information 5 - New diagnoses Route of transmission Age and gender CD4 surveillance

More information

Hepatitis C Treatment of Active IV Drug Users Tania Dunn, RN Isabelle Gendron, RN B.Sc.

Hepatitis C Treatment of Active IV Drug Users Tania Dunn, RN Isabelle Gendron, RN B.Sc. Hepatitis C Treatment of Active IV Drug Users Tania Dunn, RN Isabelle Gendron, RN B.Sc. CRD Le Virage Équipe TDO GMF de l UMF Charles LeMoyne St-Lambert, Quebec February 2012 Potential Conflicts of Interest

More information

Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa

Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa David Coetzee a, Andrew Boulle a, Katherine Hildebrand a, Valerie Asselman b, Gilles

More information

Viral load testing. medical monitoring: viral load testing: 1

Viral load testing. medical monitoring: viral load testing: 1 medical monitoring: viral load testing: 1 medical monitoring: viral load testing Viral load testing medical monitoring: viral load testing: 2 Slide 1 Viral load The viral load test measures HIV in the

More information

Population Pharmacokinetics of Atazanavir in Naïve HIV Infected Patients using Medication Events Monitoring System (MEMS) for drug intake timing

Population Pharmacokinetics of Atazanavir in Naïve HIV Infected Patients using Medication Events Monitoring System (MEMS) for drug intake timing Population Pharmacokinetics of Atazanavir in Naïve HIV Infected Patients using Medication Events Monitoring System (MEMS) for drug intake timing ANRS -COPHAR clinical trial Céline Verstuyft Pharmacologie,

More information

Curriculum vitae. Safy Zahid Kaddah. Assistant professor of chest diseases department, Cairo University.

Curriculum vitae. Safy Zahid Kaddah. Assistant professor of chest diseases department, Cairo University. Curriculum vitae Safy Zahid Kaddah Assistant professor of chest diseases department, Cairo University. The chest diseases department coordinate of the technical support office for projects and grants Kasr

More information

STOP HIV/AIDS Pilot Project

STOP HIV/AIDS Pilot Project STOP HIV/AIDS Pilot Project INDICATORS QUARTERLY REPORT: 1 October through 31 December SUBMITTED TO: The BC Ministry of Health Services SUBMITTED BY: Dr. Rolando Barrios, Dr. Mark Gilbert, Dr. Kate Health,

More information

Status of HIV / AIDS epidemic in Turkey

Status of HIV / AIDS epidemic in Turkey Acta Medica 2012; 1: 19 24 acta medica REVIEW ARTICLE Status of HIV / AIDS epidemic in Turkey Tuğrul ERBAYDAR 1 [MD, PhD] Nüket Paksoy ERBAYDAR 2 * [MD, MSc] 1 Ankara University Faculty of Medicine Department

More information

Global Update on HIV Treatment 2013: Results, Impact and Opportunities

Global Update on HIV Treatment 2013: Results, Impact and Opportunities June 2013 Global Update on HIV Treatment 2013: Results, Impact and Opportunities WHO/UNAIDS/UNICEF v2 Outline Results: Progress towards Global Targets - Antiretroviral treatment - Prevention of mother-to-child

More information

Le métier d'infectiologue en Europe. Bruno Hoen Université de Franche Comté CHU de Besançon EGI 14 janvier 2011

Le métier d'infectiologue en Europe. Bruno Hoen Université de Franche Comté CHU de Besançon EGI 14 janvier 2011 Le métier d'infectiologue en Europe Bruno Hoen Université de Franche Comté CHU de Besançon EGI 14 janvier 2011 Une définition européenne de l'infectiologie? Les infectiologues en Europe? Pas dans tous

More information

Core Competencies: HIV/AIDS: HIV Basics HIV/AIDS JEOPARDY* Overview. To change category names: Instructions. 2. Introduce session.

Core Competencies: HIV/AIDS: HIV Basics HIV/AIDS JEOPARDY* Overview. To change category names: Instructions. 2. Introduce session. Core Competencies: HIV/AIDS: HIV Basics HIV/AIDS JEOPARDY* ABOUT THIS ACTIVITY Time: 60 minutes Objectives: By the end of this session, participants will be able to: Reviewed their knowledge of HIV/AIDS

More information

ACCESS TO AFFORDABLE TREATMENT FOR HIV/AIDS: THE ISSUES

ACCESS TO AFFORDABLE TREATMENT FOR HIV/AIDS: THE ISSUES ACCESS TO AFFORDABLE TREATMENT FOR HIV/AIDS: THE ISSUES AIDS Law Unit Legal Assistance Centre July, 2002 INTRODUCTION Although there is currently no cure for HIV/Aids, treatment has, however, been developed

More information

Guideline. Treatment of tuberculosis in patients with HIV co-infection. Version 3.0

Guideline. Treatment of tuberculosis in patients with HIV co-infection. Version 3.0 Guideline Treatment of tuberculosis in patients with HIV co-infection Version 3.0 Key critical points Co-infection with Tuberculosis (TB) and HIV is common in many parts of the world, especially sub-saharan

More information

Chairperson of the NEPAD Heads of State and Government Orientation Committee, President Macky Sall of the Republic of Senegal

Chairperson of the NEPAD Heads of State and Government Orientation Committee, President Macky Sall of the Republic of Senegal Results-based Performance Report of the NEPAD Agency Presented to 32 th NEPAD HSGOC by Dr. Ibrahim Assane Mayaki, Chief Executive Officer, NEPAD Agency 29 January 2015 Excellences, Chairperson of the NEPAD

More information

Réservoirs VIH : du contrôle à l'éradication. Asier Sáez-Cirión, PhD Unité de Régulation des Infections Rétrovirales

Réservoirs VIH : du contrôle à l'éradication. Asier Sáez-Cirión, PhD Unité de Régulation des Infections Rétrovirales Réservoirs VIH : du contrôle à l'éradication Asier Sáez-Cirión, PhD Unité de Régulation des Infections Rétrovirales M. Coiras et al Nat Rev Micro 2009 HIV-1 life cycle and latency HIV-1 life cycle and

More information

HIV New Diagnoses, Treatment and Care in the UK 2015 report

HIV New Diagnoses, Treatment and Care in the UK 2015 report HIV New Diagnoses, Treatment and Care in the UK 2015 report About Public Health England Public Health England exists to protect and improve the nation's health and wellbeing, and reduce health inequalities.

More information

HIV/AIDS MORTALITY. SPAIN,

HIV/AIDS MORTALITY. SPAIN, SECRETARÍA GENERAL DE SANIDAD DIRECCIÓN GENERAL DE SALUD PÚBLICA Y SANIDAD EXTERIOR HIV/AIDS MORTALITY. SPAIN, 1981-2008 May 2010 MORTALITY FROM HIV/AIDS IN SPAIN, 1981-2008 INTRODUCTION Despite greatly

More information

Monitoring HIV/AIDS Programs: Participant Guide

Monitoring HIV/AIDS Programs: Participant Guide Monitoring HIV/AIDS Programs: Participant Guide A USAID Resource for Prevention, Care and Treatment Module 10: September 2004 Family Health International In July 2011, FHI became FHI 360. FHI 360 is a

More information

Journal of Epidemiology Vol. 14, No. 6 November 2004

Journal of Epidemiology Vol. 14, No. 6 November 2004 Journal of Epidemiology Vol. 14, No. 6 November 2004 HIV/AIDS surveillance, which reveals trends in the numbers of patients with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome

More information

HIV Drug Resistance in the Asia- Pacific

HIV Drug Resistance in the Asia- Pacific HIV Drug Resistance in the Asia- Pacific David A Cooper National Centre in HIV Epidemiology and Clinical Research The University of New South Wales Sydney, Australia HIVDR in Asia Pacific Transmitted resistance

More information

The Value of Innovation in HIV/AIDS Therapy

The Value of Innovation in HIV/AIDS Therapy White Paper September 2014 The Value of Innovation in HIV/AIDS Therapy Erin Ellwanger, Harrison Kim, and Thomas Goss, PharmD Boston Healthcare Associates, Inc. Boston; Washington, D.C.; Berlin; Shangai;

More information

HIV Guidelines. New Strategies.

HIV Guidelines. New Strategies. HIV Guidelines. New Strategies. Santiago Moreno Hospital Universitario Ramón y Cajal Madrid HIV Guidelines. New Strategies. Outline HIV Guidelines What is new? New strategies Treatment as Prevention HIV

More information

hiv/aids Programme Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants

hiv/aids Programme Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants hiv/aids Programme Programmatic update Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants EXECUTIVE SUMMARY April 2012 EXECUTIVE SUMMARY Recent developments

More information

APPENDIX C: Viral Load Suppression Measures

APPENDIX C: Viral Load Suppression Measures Newark EMA HIV Health Services Planning Council Needs Assessment 2012 Update APPENDIX C: Viral Load Suppression Measures Page C-1 APPENDIX C: Viral Load Suppression Measures in+care Campaign Measures November

More information

Synthesis of ECT evidence

Synthesis of ECT evidence Efficacy Synthesis of ECT evidence Risk Reference : Agence d évaluation des technologies et des modes d intervention en santé (AETMIS). The use of electroconvulsive therapy in Québec. Report prepared by

More information

FEDERAL BUREAU OF PRISONS REPORT ON INFECTIOUS DISEASE MANAGEMENT

FEDERAL BUREAU OF PRISONS REPORT ON INFECTIOUS DISEASE MANAGEMENT FEDERAL BUREAU OF PRISONS REPORT ON INFECTIOUS DISEASE MANAGEMENT What is the purpose of this report? The purpose of this report is to present the administrative policies and clinical guidelines for the

More information

HIV/AIDS Prevention and Care

HIV/AIDS Prevention and Care HIV/AIDS Prevention and Care Nancy S. Padian, PhD, MPH Professor, Obstetrics, Gynecology & Reproductive Sciences Associate Director for Research, Global Health Sciences and AIDS Research Institute: University

More information

INTERVENTION PROVIDING FEEDBACK TO PHYSICIANS AND PHARMACISTS TO IMPROVE DRUG USE

INTERVENTION PROVIDING FEEDBACK TO PHYSICIANS AND PHARMACISTS TO IMPROVE DRUG USE INTERVENTION PROVIDING FEEDBACK TO PHYSICIANS AND PHARMACISTS TO IMPROVE DRUG USE Final Report Submitted to the Canadian Health Services Research Foundation October 2004 Régis Blais, Ph.D. Claudine Laurier,

More information

Aids Fonds funding for programmes to prevent HIV drug resistance

Aids Fonds funding for programmes to prevent HIV drug resistance funding for programmes to prevent HIV drug resistance Call for proposals July 2012 Page 1 van 10 grants@aidsfonds.nl Documentnumber 20120719/JKA/RAP Universal Access Lifting barriers to universal access

More information

EYE DISEASES IN HIV-INFECTED INDIVIDUALS IN RURAL SOUTH AFRICA

EYE DISEASES IN HIV-INFECTED INDIVIDUALS IN RURAL SOUTH AFRICA EYE DISEASES IN HIV-INFECTED INDIVIDUALS IN RURAL SOUTH AFRICA In our Western world where treatment is available, HIV/AIDS has become a chronic disease. In all other parts of the globe, HIV/AIDS is still

More information

Session 4: The Drug Management Cycle: Selection. David Peters

Session 4: The Drug Management Cycle: Selection. David Peters This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Without AIDS Scenario Population (1,000s) 10,186 10,978 Growth rate 2.8 2.9 Crude birth rate 40 39 Crude death rate 14 12

Without AIDS Scenario Population (1,000s) 10,186 10,978 Growth rate 2.8 2.9 Crude birth rate 40 39 Crude death rate 14 12 Demographic Indicators With AIDS Series Without AIDS Scenario With AIDS Series Without AIDS Scenario Population (1,s),186,978 Growth rate 2.8 2.9 Crude birth rate 4 39 Crude death rate 14 12 Infant mortality

More information

HIV/AIDS Care: The Diagnosis Code Series 2. Prepared By: Stacey L. Murphy, MPA, RHIA, CPC AHIMA Approved ICD-10-CM/ICD-10-CM Trainer

HIV/AIDS Care: The Diagnosis Code Series 2. Prepared By: Stacey L. Murphy, MPA, RHIA, CPC AHIMA Approved ICD-10-CM/ICD-10-CM Trainer HIV/AIDS Care: The Diagnosis Code Series 2 Prepared By: Stacey L. Murphy, MPA, RHIA, CPC AHIMA Approved ICD-10-CM/ICD-10-CM Trainer Learning Outcomes Identify and explain the difference between ICD-9-CM

More information

Incidencia y Características Clínicas del Síndrome Inflamatorio de Reconstitución Inmune (IRIS) en el Contexto de la Coinfección VIH-TB

Incidencia y Características Clínicas del Síndrome Inflamatorio de Reconstitución Inmune (IRIS) en el Contexto de la Coinfección VIH-TB Incidencia y Características Clínicas del Síndrome Inflamatorio de Reconstitución Inmune (IRIS) en el Contexto de la Coinfección VIH-TB Dr. Christian Manzardo Hospital Clínic/IDIBAPS- Universidad de Barcelona

More information

Summary of Key Findings

Summary of Key Findings Summary of Key Findings mothers2mothers Internal Programme Evaluation July 2014 Department of Programmes and Technical Support mothers2mothers An evaluation of the prevention of mother-to-child transmission

More information

In Tanzania, ARVs were introduced free-of-charge by the government in 2004 and, by July 2008, almost 170,000 people were receiving the drugs.

In Tanzania, ARVs were introduced free-of-charge by the government in 2004 and, by July 2008, almost 170,000 people were receiving the drugs. ANTIRETROVIRAL TREATMENT What is ART and ARV? ART is a short form for Antiretroviral Therapy (or Treatment). Antiretroviral therapy is a treatment consisting of a combination of drugs which work against

More information

Frequently Asked Questions (FAQs)

Frequently Asked Questions (FAQs) Frequently Asked Questions (FAQs) Research Rationale 1. What does PrEP stand for? There is scientific evidence that antiretroviral (anti-hiv) medications may be able to play an important role in reducing

More information

Recognizing the Value of Innovation in HIV/AIDS Therapy

Recognizing the Value of Innovation in HIV/AIDS Therapy White Paper December 2012 Recognizing the Value of Innovation in HIV/AIDS Therapy Catherine Augustyn, Brigham Walker, and Thomas F. Goss, PharmD Boston Healthcare Associates, Inc., Boston, MA and Washington,

More information

AIMS ESSAY PRESENTATION

AIMS ESSAY PRESENTATION JAMES MALM AFRICAN INSTITUTE FOR MATHEMATICAL SCIENCES AIMS ESSAY PRESENTATION 1 Long term Dynamics of HIV disease progression with a non-sterilizing vaccine 0.1 Introduction Vaccines have been used for

More information

Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational HIV Vaccine Candidate

Vaccination and Enrollment Are Discontinued in Phase II Trials of Merck's Investigational HIV Vaccine Candidate News Release FOR IMMEDIATE RELEASE Merck Contact: Mary Elizabeth Blake (215) 652-5558 Merck Investor Contact: Graeme Bell (908) 423-5185 HVTN Contact: Sarah Alexander (206) 910-3801 Vaccination and Enrollment

More information

HIV DRUG RESISTANCE EARLY WARNING INDICATORS

HIV DRUG RESISTANCE EARLY WARNING INDICATORS HIV DRUG RESISTANCE EARLY WARNING INDICATORS World Health Organization indicators to monitor HIV drug resistance prevention at antiretroviral treatment sites June 2010 Update ACKNOWLEDGEMENTS The preparation

More information

Paediatric HIV Drug Resistance in African Settings

Paediatric HIV Drug Resistance in African Settings Paediatric HIV Drug Resistance in African Settings Dr Cissy Kityo Mutuluuza INTEREST Meeting May 5-9, 2014 Lusaka, Zambia Background: ART for children in sub- Saharan Africa 2.3 million children with HIV

More information

Curriculum Vitae Nadia NAAMI

Curriculum Vitae Nadia NAAMI Nadia Naami Ph.D. Candidate in Romance Studies Department of Modern Languages and Literatures University of Miami 5202 University Drive Coral Gables, FL 33124-2074 Tel: 786-603-8795 email :n.naami@umiami.edu

More information

CURRICULUM VITAE. Contact: Tel: ; ; Fax: who.int

CURRICULUM VITAE. Contact: Tel: ; ; Fax: who.int CURRICULUM VITAE Name: Address: KHALID SAEED Regional office of the Eastern Mediterranean, World Health Organisation,Abdul Razzak Al Sanhouri Street, Nasr city P.O Box 7608; Cairo Egypt,11371 Date of Birth:

More information

Routine HIV Monitoring

Routine HIV Monitoring Routine HIV Monitoring Guideline of the HIV/AIDS Division at San Francisco General Hospital Statement of Guideline: Patients will be routinely evaluated and monitored for HIV parameters, antiretroviral

More information

EXPANDED HIV TESTING AND LINKAGE TO CARE (X-TLC) IN HEALTHCARE SETTINGS ON THE SOUTH SIDE OF CHICAGO

EXPANDED HIV TESTING AND LINKAGE TO CARE (X-TLC) IN HEALTHCARE SETTINGS ON THE SOUTH SIDE OF CHICAGO EXPANDED HIV TESTING AND LINKAGE TO CARE (X-TLC) IN HEALTHCARE SETTINGS ON THE SOUTH SIDE OF CHICAGO R Eavou, M Taylor, C Bertozzi-Villa, D Amarathithada, R Buffington, D Pitrak and N Benbow HIV Prevention

More information

Protocol for the systematic review of virological outcomes after 12 Months of antiretroviral therapy in low and middle income countries

Protocol for the systematic review of virological outcomes after 12 Months of antiretroviral therapy in low and middle income countries Protocol for the systematic review of virological outcomes after 12 Months of antiretroviral therapy in low and middle income countries 1. Authors James H. McMahon Alfred Hospital, Melbourne, Australia

More information

Thinking about TB elimination at home and abroad

Thinking about TB elimination at home and abroad Global tuberculosis incidence Thinking about TB elimination at home and abroad Neil W. Schluger, M.D. Professor of Medicine, Epidemiology, and Environmental Health Science Columbia University Overall:

More information

Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts

Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts Published by Oxford University Press on behalf of the International Epidemiological Association International Journal of Epidemiology 2005;34:979 986 Ó The Author 2005; all rights reserved. Advance Access

More information

Cascade of Care and its relevance to Seek, Test, Treat and Retain Strategy. Carlos del Rio, MD Emory Center for AIDS Research

Cascade of Care and its relevance to Seek, Test, Treat and Retain Strategy. Carlos del Rio, MD Emory Center for AIDS Research Cascade of Care and its relevance to Seek, Test, Treat and Retain Strategy Carlos del Rio, MD Emory Center for AIDS Research In order for a person to benefit from HIV treatment success it is necessary

More information

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents Visit the AIDSinfo website to access the most up-to-date guideline. Register for e-mail notification of guideline

More information

Case Finding for Hepatitis B and Hepatitis C

Case Finding for Hepatitis B and Hepatitis C Case Finding for Hepatitis B and Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Atlanta, Georgia, USA Division of Viral Hepatitis National Center

More information

Improving primary care management of depression in adults with comorbid chronic illnesses

Improving primary care management of depression in adults with comorbid chronic illnesses Executive summary of current research Improving primary care management of depression in adults with comorbid chronic illnesses Principal Investigator Jane McCusker, MD DrPH Co-Investigators Martin Cole,

More information

Expérience appui ANR Zimbabwe (Medicines Control Authority of Zimbabwe -MCAZ) Corinne Pouget -AEDES

Expérience appui ANR Zimbabwe (Medicines Control Authority of Zimbabwe -MCAZ) Corinne Pouget -AEDES Expérience appui ANR Zimbabwe (Medicines Control Authority of Zimbabwe -MCAZ) Corinne Pouget -AEDES 1 Zimbabwe Pharmaceutical Industry The Market Small Country of ca.13 million people Human Pharmaceutical

More information

5èmes journées du Site ANRS-Cameroun Yaoundé, 3-4 juin 2013 ANRS-12235

5èmes journées du Site ANRS-Cameroun Yaoundé, 3-4 juin 2013 ANRS-12235 èmes journées du Site ANRS-Cameroun Yaoundé, -4 juin 201 ANRS-122 Le sang total séché sur papier filtre, DBS (Dried Blood Spot), est-il utilisable pour le suivi virologique en routine des patients VIH+

More information

Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management

Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management Bloodborne Pathogens Exposure Policy and Procedures Employees of the State of South Dakota Department of Health Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management PEP Hotline 1-888-448-4911 DOH

More information

French policy on access to care for illegal immigrants living with HIV: advantages, limits and improvement levers

French policy on access to care for illegal immigrants living with HIV: advantages, limits and improvement levers French policy on access to care for illegal immigrants living with HIV: Michel CELSE 1, Laurent GEFFROY 1, Pierre-Yves GEOFFARD 1, Patrick YENI 1, Commission on migrants of the French National AIDS Council

More information

HIV Therapy Key Clinical Indicator (KCI)

HIV Therapy Key Clinical Indicator (KCI) Publication Report HIV Therapy Key Clinical Indicator (KCI) Year ending 31 December 2010 Publication date 27 September 2011 A National Statistics Publication for Scotland Contents Contents... 1 About ISD...

More information

Presented By: Amy Medley PhD, MPH Centers for Disease Control and Prevention

Presented By: Amy Medley PhD, MPH Centers for Disease Control and Prevention Factors Associated with Non-Adherence to Antiretroviral Therapy among Patients Attending HIV Care and Treatment Clinics in Kenya, Namibia, and Tanzania Harriet Nuwagaba-Biribonwoha, Sherri Pals, Daniel

More information

Module 7: The Role of the Nurse

Module 7: The Role of the Nurse Module 7: The Role of the Nurse Module Objectives To describe the dynamic role of the nurse in the holistic care of a patient receiving ARV treatment To equip nurses with a sense of importance and belief

More information

Linda Beer, PhD and Jacek Skarbinski, MD for the Medical Monitoring Project

Linda Beer, PhD and Jacek Skarbinski, MD for the Medical Monitoring Project Adherence to Antiretroviral Therapy and Disparities in Viral Suppression among U.S. Black and White Men Who Have Sex With Men Medical Monitoring Project, 2009 Linda Beer, PhD and Jacek Skarbinski, MD for

More information

The Prize Fund for HIV/AIDS

The Prize Fund for HIV/AIDS The Prize Fund for HIV/AIDS A New Paradigm for Supporting Sustainable Innovation and Access to New Drugs for AIDS: De-Linking Markets for Products from Markets for Innovation May 26, 2011 Introduction

More information

Stigma and Discrimination

Stigma and Discrimination Stigma and Discrimination T he Network of Associations for Harm Reduction (NAHR) aims to reduce HIV/AIDS Stigma and Discrimination towards Most at Risk Populations (MARPs) and People Living with HIV/AIDS

More information

The use of alcohol and drugs and HIV treatment compliance in Brazil

The use of alcohol and drugs and HIV treatment compliance in Brazil The use of alcohol and drugs and HIV treatment compliance in Brazil André Malbergier, MD, PhD Hospital das Clínicas Medical School University of São Paulo Brasil The Casa da AIDS offers specialized integral

More information

Telephone: 514-878-2691 Email: parent.nicole@rcgt.com

Telephone: 514-878-2691 Email: parent.nicole@rcgt.com NICOLE PARENT, RN PHD Telephone: 514-878-2691 Email: parent.nicole@rcgt.com CAREER PROFILE Nicole Parent, RN, PhD is a Senior Consultant in s Strategy and Performance Consulting Group. She is also a nurse

More information

Journal of Infectious Diseases Advance Access published January 26, 2015

Journal of Infectious Diseases Advance Access published January 26, 2015 Journal of Infectious Diseases Advance Access published January 26, 2015 1 Effect of immune status on serial QuantiFERON-TB Gold In-Tube LTBI screening in persons with HIV in a low TB incidence country

More information

MONITORING HIV-RELATED MORTALITY IN SOUTH AFRICA: THE CHALLENGES AND URGENCY

MONITORING HIV-RELATED MORTALITY IN SOUTH AFRICA: THE CHALLENGES AND URGENCY MONITORING HIV-RELATED MORTALITY IN SOUTH AFRICA: THE CHALLENGES AND URGENCY Andrew Skingsley 1, Simbarashe Takuva 2, Alison Brown 3, Valerie Delpech 3, Adrian Puren 2 1 Imperial College, London, United

More information

Report to UNAIDS HIV/AIDS TRENDS IN JAPAN April 2016

Report to UNAIDS HIV/AIDS TRENDS IN JAPAN April 2016 Report to UNAIDS HIV/AIDS TRENDS IN JAPAN April 2016 I. Status at a glance The AIDS Surveillance Committee holds quarterly meeting to compile the annual report on the trends of new reported cases of HIV

More information

CURRICULUM VITAE. Mohamed Ali BCHIR PERSONNAL INFORMATIONS

CURRICULUM VITAE. Mohamed Ali BCHIR PERSONNAL INFORMATIONS CURRICULUM VITAE Mohamed Ali BCHIR PERSONNAL INFORMATIONS Address: ENGEES Tunisian Single 1, quai Koch - BP61039 UMR GESTE Born on April, 29 th 1980 67070 Strasbourg Driving License B Office: + 33 3 88

More information

Sub-Saharan Africa and the Indian Ocean

Sub-Saharan Africa and the Indian Ocean Region Institut Pasteur The Institut Pasteur International Network Sub-Saharan Africa and the Indian Ocean Science has no native land, it embraces all humankind. Louis Pasteur Sub-Saharan Africa and the

More information

VICTOR NABHAN. Short CV. Victor Nabhan holds LLM law degrees from the University of Lyon, University of Paris, and New York University Law Schools.

VICTOR NABHAN. Short CV. Victor Nabhan holds LLM law degrees from the University of Lyon, University of Paris, and New York University Law Schools. VICTOR NABHAN Short CV Victor Nabhan holds LLM law degrees from the University of Lyon, University of Paris, and New York University Law Schools. From 1971 until 1999 a) He was a professor of law (tenured)

More information

Comparative Drug Ranking for Clinical Decision Support in HIV Treatment

Comparative Drug Ranking for Clinical Decision Support in HIV Treatment Comparative Drug Ranking for Clinical Decision Support in HIV Treatment Emiliano Mancini University of Amsterdam 1 Prevalence of HIV 2 Global Overview HIV Infection People living with HIV: 34 million (2010

More information

The number of people living with HIV/AIDS continues to grow, estimated to be 39.5 million as

The number of people living with HIV/AIDS continues to grow, estimated to be 39.5 million as Focused Issue of This Month Epidemiology of HIV/AIDS - Current Status, Trend and Prospect - Kang Won Choe, MD Department of Internal Medicine, Seoul National University College of Medicine Email : choekw@snu.ac.kr

More information

HIV Screening and Access to Care Institute of Medicine. Jeffrey Crowley Office of National AIDS Policy

HIV Screening and Access to Care Institute of Medicine. Jeffrey Crowley Office of National AIDS Policy HIV Screening and Access to Care Institute of Medicine Jeffrey Crowley Office of National AIDS Policy ONAP Mission The Office of National AIDS Policy (ONAP) Part of the White House Domestic Policy Council

More information

L hépatite virale C en Médecine Familiale- Rurale Montréal-Québec Mai 2015

L hépatite virale C en Médecine Familiale- Rurale Montréal-Québec Mai 2015 L hépatite virale C en Médecine Familiale- Rurale Montréal-Québec Mai 2015 Demographics Luis Rivero Pinelo MD LMCC, CCFP, FCFP, Fellow SRPC, CSPQ Shawville- Québec Aux États Unis, la prévalence est présente

More information

Predictors for antiretroviral therapy (ART) failure in an urban HIV/AIDS clinic in Addis Ababa, Ethiopia

Predictors for antiretroviral therapy (ART) failure in an urban HIV/AIDS clinic in Addis Ababa, Ethiopia Predictors for antiretroviral therapy (ART) failure in an urban HIV/AIDS clinic in Addis Ababa, Ethiopia Katherine Niemeyer, Akilah King, Sophie Mengistu, Nils Hennig Department of Medical Education, Department

More information

Seek and Treat to Optimally Prevent HIV/AIDS (STOP HIV/AIDS) Evaluation and Monitoring

Seek and Treat to Optimally Prevent HIV/AIDS (STOP HIV/AIDS) Evaluation and Monitoring Seek and Treat to Optimally Prevent HIV/AIDS (STOP HIV/AIDS) Evaluation and Monitoring Collaborative A partnership between BC Ministry of Health and other agencies with the British Columbia Centre for

More information

GARPR Online Reporting Tool

GARPR Online Reporting Tool GARPR Online Reporting Tool 0 Narrative Report and Cover Sheet 1) Which institutions/entities were responsible for filling out the indicator forms? a) NAC or equivalent Yes b) NAP Yes c) Others Yes If

More information

International Symposium "Water, Recycling and Waste Valorisation ", ERVD 3 Conference center FMP-Fez, Morocco, 28 and 29 October 2015.

International Symposium Water, Recycling and Waste Valorisation , ERVD 3 Conference center FMP-Fez, Morocco, 28 and 29 October 2015. Groupe de Réflexion sur le Développement Durable 32, Rue Michlifène Lot Al Ghorfa, Rte Aïn Smen, 30 040 Fès Tél. 0672 351 191 E-mail. zerrouq1959@gmail.com Site web: www.qualisup.com International Symposium

More information

Ministère des Affaires Sociales et de la Santé, France

Ministère des Affaires Sociales et de la Santé, France Ministère des Affaires Sociales et de la Santé, France 1.1 Please indicate the type of organisation on behalf of which you are responding to this consultation: 1. Respondent Profile Public authorities

More information

HIV and Neurological complications in Thailand

HIV and Neurological complications in Thailand HIV and Neurological complications in Thailand Khuanchai Supparatpinyo Division of Infectious Disease Department of Medicine Chiang Mai University, Thailand Agenda Epidemiology of HIV in Thailand Epidemiology

More information

CURRICULUM VITAE PERSONAL INFORMATION. Scott S. Ubillos, M.D.

CURRICULUM VITAE PERSONAL INFORMATION. Scott S. Ubillos, M.D. CURRICULUM VITAE PERSONAL INFORMATION Name: Scott S. Ubillos, M.D. Office Infectious Disease Associates of Tampa Bay Address: 4 Columbia Drive, Suite 820 Tampa, FL 33606 4729 N. Habana Ave Tampa, Florida

More information

State of Alabama HIV Surveillance 2012 Annual Report Finalized

State of Alabama HIV Surveillance 2012 Annual Report Finalized State of Alabama HIV Surveillance 212 Annual Report Finalized Prepared by: Division of HIV/AIDS Prevention and Control HIV Surveillance Branch Contact Person: Allison R. Smith, MPH Allison.Smith@adph.state.al.us

More information

João Silva de Mendonça, MD, PhD Infectious Diseases Service Hospital do Servidor Público Estadual São Paulo - Brazil

João Silva de Mendonça, MD, PhD Infectious Diseases Service Hospital do Servidor Público Estadual São Paulo - Brazil Brazilian Ministry of Health, Brazilian Society of Hepatology PAHO, Viral Hepatitis Prevention Board PART III SESSION 9 Prevention and control of Viral Hepatitis in Brazil HEPATITIS IN SPECIAL RISK GROUPS/

More information

Borderless Diseases By Sunny Thai

Borderless Diseases By Sunny Thai Borderless Diseases By Sunny Thai Millennium Development Goal #6 6. Combat HIV/AIDS, malaria and other borderless diseases. A. Halt and begin reversing spread of HIV by 2015. B. Achieve universal access

More information

HIV Drug resistanceimplications

HIV Drug resistanceimplications HIV Drug resistanceimplications for therapy Deenan Pillay Africa Centre for Health and Population Studies, UKZN University College London Potential implications of HAART without virological monitoring:

More information

Table 5: HIV/AIDS statistics for Africa (excluding North Africa), 2001 and 2009

Table 5: HIV/AIDS statistics for Africa (excluding North Africa), 2001 and 2009 Table 5: HIV/AIDS statistics for Africa (excluding North Africa), 2001 and 2009 Year People living with HIV (million) People newly infected with HIV (million) Children living with HIV (million) AIDS-related

More information